EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Biologics and Selected Upper- and Lower-Airway Outcomes in AERD Subgroups: A Systematic Review and Meta-Analysis

Zusheng Du, Wei Liu, Yang Zheng, Yingxue Li, Jianbo Fu, Xicheng Song, Yu Zhang

The Journal of Allergy and Clinical Immunology: In Practice · 2026-11 · 14 (11) · 2533-2543

DOI: 10.1016/j.jaip.2026.07.031 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026-11. Verfasst von Zusheng Du und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, Yantai Yuhuangding Hospital, Qingdao University, Zhifu District, Yantai, China; Shandong Pr…. Hauptthemen laut MEDLINE: Biological Products, Asthma, Aspirin-Induced. Die Arbeit nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is a refractory type 2 inflammatory disorder affecting the unified airway. Conventional treatments offer limited efficacy with high recurrence. Biologics are approved for chronic rhinosinusitis with nasal polyps or asthma, but AERD-specific randomized controlled trials remain critically scarce, and quantitative synthesis of biologic efficacy specifically in AERD subgroups is limited. OBJECTIVE: To evaluate the efficacy of biologics on selected upper- and lower-airway outcomes in AERD subgroups. METHODS: We searched PubMed, Embase, Web of Science, Cochrane Library, and ClinicalTrials.gov for randomized controlled trials of biologics in AERD. Upper- airway outcomes included the Nasal Polyp Score, Nasal Congestion Score, 22-item Sino-Nasal Outcome Test, and University of Pennsylvania Smell Identification Test. Lower airway outcomes included the 5-item Asthma Control Questionnaire and FEV1. RESULTS: Eleven studies (15 randomized controlled trials, 818 patients with AERD) were included. Biologics significantly improved upper-airway outcomes when compared with placebo: Nasal Polyp Score (mean difference [MD], -1.33 [95% CI, -2.07 to -0.59]), Nasal Congestion Score (MD, -0.84 [95% CI, -1.15 to -0.53]), 22-item Sino-Nasal Outcome Test (MD, -19.16 [95% CI, -25.62 to -12.69]), and University of Pennsylvania Smell Identification Test (MD, 8.00 [95% CI, 1.33 to 14.66]). Lower-airway outcomes were also significantly improved: 5-item Asthma Control Questionnaire (MD, -0.90 [95% CI, -1.32 to -0.48]) and FEV1 (MD, 0.29 L [95% CI, 0.21 to 0.37]). All improvements exceeded the respective minimal clinically important difference thresholds. CONCLUSIONS: In AERD subgroups, biologics produced statistically significant and clinically meaningful improvements across all evaluated upper- and lower-airway outcomes, with pooled effect sizes exceeding respective minimal clinically important difference thresholds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological ProductsAsthma, Aspirin-InducedHumansTreatment OutcomeNasal PolypsRhinosinusitisRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Aspirin-exacerbated respiratory diseaseAsthmaBiologicsChronic rhinosinusitis with nasal polypsMeta-analysisUnified airway

Substanzen

Biological Products

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Head and Neck Surgery, Yantai Yuhuangding Hospital, Qingdao University, Zhifu District, Yantai, China; Shandong Provincial Key Laboratory of Neuroimmune Interaction and Regulation, Yan…
  • Department of Physical Examination Center, Yantai Yuhuangding Hospital, Qingdao University, Yantai, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Du, Z., Liu, W., Zheng, Y., Li, Y., Fu, J., Song, X., & Zhang, Y. (2026). Biologics and Selected Upper- and Lower-Airway Outcomes in AERD Subgroups: A Systematic Review and Meta-Analysis. The Journal of Allergy and Clinical Immunology: In Practice, 14(11), 2533-2543. https://doi.org/10.1016/j.jaip.2026.07.031

Vancouver

Du Z, Liu W, Zheng Y, Li Y, Fu J, Song X, et al. Biologics and Selected Upper- and Lower-Airway Outcomes in AERD Subgroups: A Systematic Review and Meta-Analysis. The Journal of Allergy and Clinical Immunology: In Practice. 2026;14(11):2533-2543. doi:10.1016/j.jaip.2026.07.031

BibTeX
@article{Du2026,
  author = {Du, Zusheng and Liu, Wei and Zheng, Yang and Li, Yingxue and Fu, Jianbo and Song, Xicheng and Zhang, Yu},
  title = {Biologics and Selected Upper- and Lower-Airway Outcomes in AERD Subgroups: A Systematic Review and Meta-Analysis},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2026},
  volume = {14},
  number = {11},
  pages = {2533--2543},
  doi = {10.1016/j.jaip.2026.07.031}
}
Kostenlos starten →